InterMune Inc
update 05/24
9.58
-0.38 (-3.82%%)
TODAY
High 9.87
Low 9.53
Open 9.87
Volume 826352
Time 05/24
52 WEEK SUMMARY
High 12.77
Low 7.21
P/E 0.00
Return
-10.72%
Mkt Cap
781.912 M
InterMune, Inc. is a biotechnology company. The Company's focus is on the research, development and commercialization of therapies in pulmonology and fibrotic diseases. InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor pulmonary and fibrotic diseases.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=970140208&utmp=%2Fquote%2FITMN%3AUS&utmhn=10.248.179.13&utmac=UA-11413116-12&utmhid=600397620)